## SNPS: Synopsys, Inc. - XLK: Technology

### Executive Summary

PARABOLIC warning: MRS_10 at 7.7% exceeds exhaustion threshold (8.0%). Extreme momentum typically precedes mean reversion. Consider profit-taking or tight stops.

- **Horizon:** 1-5 days (momentum)
- **Risk Profile:** High - extreme momentum reversal risk
- **Stop Type:** Fixed 2xATR ($431.92)
- **If Wrong:** Exit on momentum reversal or stop hit
- **Invalidation:** MRS_10 drops below exhaustion threshold

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 0, Bearish: 9)

**1. Synopsys Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Synopsys, Inc. - SNPS**
- Source: WANE 15 | 20251204T230833 | Bearish | Relevance: 100%
- ClaimsFiler is reminding Synopsys investors who incurred losses exceeding $100,000 to file lead plaintiff applications in securities class action lawsuits by December 30, 2025. The lawsuit alleges that Synopsys failed to disclose material information during the Class Period, leading to a significant drop in share price after the announcement of disappointing Q3 2025 financial results. Investors who purchased Synopsys securities between December 4, 2024, and September 9, 2025, or acquired Synopsys stock in exchange for Ansys shares, may be affected.

**2. INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Synopsys**
- Source: Morningstar | 20251204T170900 | Bearish | Relevance: 100%
- Faruqi & Faruqi, LLP is investigating potential securities fraud claims against Synopsys, Inc. (NASDAQ: SNPS) on behalf of investors who purchased securities between December 4, 2024, and September 9, 2025. The lawsuit alleges that Synopsys made misleading statements regarding its Design IP business, leading to a significant stock price drop following disappointing Q3 2025 financial results. Investors have until December 30, 2025, to seek the role of lead plaintiff in the federal securities class action.

**3. INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Synopsys**
- Source: WANE 15 | 20251204T160841 | Bearish | Relevance: 100%
- Faruqi & Faruqi, LLP is investigating potential claims against Synopsys, Inc. (NASDAQ: SNPS) on behalf of investors who purchased securities between December 4, 2024, and September 9, 2025. The investigation follows allegations that Synopsys made misleading statements regarding its business operations, particularly concerning its Design IP business, which subsequently led to a significant drop in its stock price after disappointing Q3 2025 financial results. Investors have until December 30, 2025, to seek the role of lead plaintiff in the federal securities class action.

**4. SNPS SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Synopsys, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!**
- Source: KXAN Austin | 20251204T150939 | Bearish | Relevance: 100%
- Bronstein, Gewirtz and Grossman, LLC has announced a class action lawsuit against Synopsys, Inc. (NASDAQ: SNPS) on behalf of investors who purchased securities between December 4, 2024, and September 9, 2025. The lawsuit alleges that Synopsys made materially false and misleading statements, particularly regarding the negative impact of its increased focus on AI customers on its Design IP business economics. Investors with substantial losses have an opportunity to lead the class action by December 30, 2025.

**5. SNPS Investors Have Opportunity to Lead Synopsys, Inc. Securities Fraud Lawsuit with the Schall Law Firm**
- Source: Morningstar | 20251204T130931 | Bearish | Relevance: 100%
- The Schall Law Firm has announced a class action lawsuit against Synopsys, Inc. (NASDAQ: SNPS) for alleged securities fraud, encouraging investors who purchased securities between December 4, 2024, and September 9, 2025, to join. The lawsuit claims Synopsys made misleading statements regarding its increased focus on AI customers negatively impacting its Design IP business. Investors who suffered losses are urged to contact the firm before December 30, 2025.

### Analyst Activity

**Target Signal:** BEARISH (Raises: 0, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-03 | Keybanc | $575 | $590 | -3% |
| 2025-11-25 | Wells Fargo | $445 | $550 | -19% |
| 2025-11-24 | Citigroup | $580 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-03 | Keybanc | main | Overweight |
| 2025-11-25 | Wells Fargo | main | Equal-Weight |
| 2025-11-24 | Citigroup | init | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 9 ($0.00M) |
| Sells | 4 ($0.06M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.5% (+20.7%)
- Blackrock Inc.: 7.9% (+18.5%)
- State Street Corpora: 4.6% (+20.6%)
- Capital World Invest: 3.9% (-3.7%)
- FMR, LLC: 3.0% (+47.5%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +4.9% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 2.99 signals overvaluation risk, limited margin of safety. Quality metrics strong (margin 19%). Analyst sentiment negative (2 target cuts vs 0 raises). Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $91.3B |
| Beta | 1.15 |
| 52W Range | $365.74 - $651.73 |
| Short Interest | 2.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.99 |
| Forward P/E | 27.4 |
| Current P/E | 32.2 |
| YoY Growth | 17.7% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from 2.8% to 7.7% (+4.9% in 5 days), confirming momentum buildup. Extended beyond STRENGTH zone (7.7% > 6.0%), caution on chasing. MRS_5 at 3.3% confirms short-term momentum alignment. Outperforming sector by 7.8pp, stock-specific strength. Below SMA200 (0.95x), long-term trend not supportive. MACD histogram positive (11.08), confirming momentum. OFD pattern: +SBL (Volatile).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 7.69% (CS: 94) | Strong |
| RSI_14 | 66.9 | Neutral |
| MACD Histogram | 11.08 | Bullish |
| vs SMA20 | 1.137x | Above |
| vs SMA50 | 1.056x | Above |
| vs SMA200 | 0.950x | Below |

### Decision

- **Verdict:** SELL
- **Thesis:** PARABOLIC

### Trade Setup

- **Entry:** $463.74
- **Stop Loss:** $431.92 (6.9% risk)
- **Target:** $495.56 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** PARABOLIC thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 31
- **Position Value:** $14,375.94
- **Portfolio %:** 14.38%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at 15.78 indicates calm conditions but breadth at 53% suggests narrow participation. Fed policy remains neutral with 42 days to next meeting, supporting steady positioning with sector selectivity.*

### Earnings

**Next:** 2025-12-10 (Est: $2.88)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $2.88 | $2.90 | +0.7% |
| 2025Q3 | $3.75 | $3.39 | -9.5% |
| 2025Q2 | $3.40 | $3.67 | +8.0% |
| 2025Q1 | $2.79 | $3.03 | +8.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*